Nano-X Imaging (NNOX) said Thursday that the US Food and Drug Administration has approved its Nanox.ARC X imaging system.
The company said Nanox.ARC X features its digital Nanox.SOURCE and advanced tomosynthesis technology.
The approval covers the system's production of tomographic images for general use, the company added.
Nano-X Imaging said it is set to start offering Nanox.ARC X later this year.
Price: 4.95, Change: +0.45, Percent Change: +10.00
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。